Laronde Aims To Advance Its eRNA Therapies In Eight Weeks, And Has $440m To Help

 
• By Mandy Jackson
  
US dollars on yellow background
CEO Diego Miralles said Laronde's big aspirations require a lot of capital • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business